Publication: Preliminary analysis of the association of TRPV1 to the formation of Marfan syndrome aneurysms
Authors
Soto, María Elena ; Soria Castro, Elizabeth ; Guarner Lans, Verónica ; Martínez Guzmán, Andrés ; Morales Marín, Cesar Amilcar ; Martínez Zavala, Karla Susana ; Pérez Torres, Israel
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-127
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Marfan syndrome (MS) is an autosomal
dominant disorder of connective tissue that is caused by
mutations in the fibrillin-1 (FBN-1) gene that cause
degeneration of the artery. It is accompanied by
endothelial dysfunction. The potential transient receptor
of the vanilloid subfamily 1 (TRPV1) ion channel plays
an important role in endothelial vascular functioning.
Here we determine the association of the presence
TRPV1 in aortic aneurysm with dilation and dissection
of the artery in MS patients. Histological sections of
aortic aneurysm tissue obtained by the surgical
procedure of Bentall and De Bono or David, were
processed by immunohistochemistry with antibodies
against ICAM, VCAM, iNOS, eNOS, TRPV1 and TNF-
α and the immunolabelling area was determined. We
also measured the NO 3- /NO 2- ratio in the aortic tissue.
C-reactive protein and HDL in plasma were quantified.
A significant increase in iNOS, TRPV1, VCAM
(p≤0.05), NO 3- /NO 2- ratio (p=0.002) and a significant
decrease in eNOS (p=0.04) and HDL in plasma (p=0.02)
in the MS vs. the C group were found. Conclusion:
TRPV1 is over-expressed in aortic tissue from MS
patients and can be associated with increases in iNOS,
VCAM and a decrease in eNOS. These changes might
contribute to the progression and rupture of the thoracic
aneurysm.
publication.page.subject
Citation
Histology and Histopathology Vol. 34, nº 12 (2019)
item.page.embargo
Ir a Estadísticas
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/